[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.194.83. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,828
Citations 0
Research Letter
April 9, 2019

Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions

Author Affiliations
  • 1Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco
  • 2Department of Social and Behavioral Sciences, University of California, San Francisco
  • 3Department of Community Health Systems, University of California, San Francisco
JAMA. 2019;321(14):1407-1408. doi:10.1001/jama.2019.0834

There is a shortage of clinicians authorized to prescribe medications to treat opioid use disorder.1,2 Nurse practitioners (NPs) and physician assistants (PAs) were allowed to obtain waivers to prescribe buprenorphine beginning in 2016.3,4 We investigated the proportions of NPs and PAs with waivers in 2018 and the association with state regulations that restrict their scope of practice.

×